BBBT (Black Bird Biotech) Total Liabilities: $1.02 Mil (As of Sep. 2023)


What is Black Bird Biotech Total Liabilities?

Black Bird Biotech BBBT -99.00% Total Liabilities is $1.02 Mil as of Sep. 2023.

Black Bird Biotech's Total Liabilities for the quarter that ended in Sep. 2023 was $1.02 Mil.

Black Bird Biotech's quarterly Total Liabilities increased from Mar. 2023 ($0.92 Mil) to Jun. 2023 ($0.98 Mil) and increased from Jun. 2023 ($0.98 Mil) to Sep. 2023 ($1.02 Mil).

Black Bird Biotech's annual Total Liabilities increased from Dec. 2020 ($0.10 Mil) to Dec. 2021 ($0.10 Mil) and increased from Dec. 2021 ($0.10 Mil) to Dec. 2022 ($0.87 Mil).


Black Bird Biotech Total Liabilities Historical Data

* Premium members only.

The historical data trend for Black Bird Biotech's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Black Bird Biotech Total Liabilities Chart

Black Bird Biotech Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.02 1.14 0.10 0.10 0.87

Black Bird Biotech Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.83 0.87 0.92 0.98 1.02

Black Bird Biotech Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Black Bird Biotech's Total Liabilities for the fiscal year that ended in Dec. 2022 is calculated as

Total Liabilities=Total Assets (A: Dec. 2022 )-Total Equity (A: Dec. 2022 )
=0.219--0.65
=0.87

Black Bird Biotech's Total Liabilities for the quarter that ended in Sep. 2023 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=1.019+(0.003+1.1362438767648E-16
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=1.02

Total Liabilities=Total Assets (Q: Sep. 2023 )-Total Equity (Q: Sep. 2023 )
=0.099--0.923
=1.02

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of $1.02 Mil mean?
Black Bird Biotech (BBBT) has a Total Liabilities of $1.02 Mil as of Sep. 2023. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Black Bird Biotech and its competitors.
Is Black Bird Biotech's Total Liabilities too high?
Black Bird Biotech's current Total Liabilities is $1.02 Mil.
How does Black Bird Biotech's Total Liabilities compare to BLMS and INLB?
Black Bird Biotech's Total Liabilities of $1.02 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Drug Manufacturers company?
A good Total Liabilities depends on the Drug Manufacturers industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Black Bird Biotech and its competitors. Black Bird Biotech's current Total Liabilities is $1.02 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Black Bird Biotech stock overvalued right now?
Black Bird Biotech (BBBT) has a current Total Liabilities of $1.02 Mil. The current Total Liabilities is $1.02 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Black Bird Biotech (BBBT), the current Total Liabilities is $1.02 Mil as of Sep. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Black Bird Biotech Business Description

Address 2801 E Camelback Road, Suite 200, Phoenix, AZ, USA, 85016
Black Bird Biotech Inc is a licensed grower of industrial hemp under the Montana Hemp Pilot Program. In addition, it is the distributor in the U. S. and Canada for MiteXstream, an EPA-registered plant-based biopesticide effective in the eradication of spider mites, a pest that destroys crops, especially cannabis, hops, coffee, and house plants, as well as molds and mildew. Its products include MiteXstream Biopesticide, Grizzly Creek Naturals, and Black Bird American Hemp.